Cargando…
Pathophysiology of diabetic dyslipidaemia: where are we?
Cardiovascular disease is a major cause of morbidity and mortality in patients with type 2 diabetes mellitus, with a two- to fourfold increase in cardiovascular disease risk compared with non-diabetic individuals. Abnormalities in lipid metabolism that are observed in the context of type 2 diabetes...
Autor principal: | Vergès, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392164/ https://www.ncbi.nlm.nih.gov/pubmed/25725623 http://dx.doi.org/10.1007/s00125-015-3525-8 |
Ejemplares similares
-
Diabetic dyslipidaemia
por: C. Thambiah, Subashini, et al.
Publicado: (2021) -
Diabetic cardiomyopathy: where we are and where we are going
por: Lee, Wang-Soo, et al.
Publicado: (2017) -
Osteoarthritis and Diabetes: Where Are We and Where Should We Go?
por: Alenazi, Aqeel M., et al.
Publicado: (2023) -
Pathophysiology, risk, diagnosis, and management of venous thrombosis in space: where are we now?
por: Harris, Katie M., et al.
Publicado: (2023) -
Treatment of Dyslipidaemia in Children
por: Fiorentino, Riccardo, et al.
Publicado: (2021)